Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 3/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.39 |
| ▸ | CTSL | P07711 | 2/20 | 0.39 |
| ▸ | CTSB | P07858 | 2/20 | 0.39 |
| ▸ | CTSS | P25774 | 2/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | GLS | O94925 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 2/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6363168 | 0.85 | HTR2C (0.41) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6368953 | 0.81 | HTR2C (0.39) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6362442 | 0.81 | HTR2C (0.39) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6368947 | 0.78 | KMT2A (0.35) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6364351 | 0.78 | GBA1 (0.34) | HTR2CSLC6A4GBA1GLSBRD4 | |
| SCHEMBL6363912 | 0.78 | BCHE (0.34) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6363358 | 0.78 | RAB9A (0.43) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6367828 | 0.78 | KMT2A (0.52) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6369123 | 0.78 | ACHE (0.38) | HTR2CSLC6A4CTSLCTSBCTSS | |
| SCHEMBL6363734 | 0.78 | KMT2A (0.35) | HTR2CSLC6A4CTSLCTSBCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9476883-B2 | Cellular recognition conjugates and methods of use for the histological analysis of cancer tissue using MALDI-MS imaging | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9476883-B2 | Cellular recognition conjugates and methods of use for the histological analysis of cancer tissue using MALDI-MS imaging | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-20140315220-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-10-23 | — | — | US | disclosed |
| US-20140315220-A1 | CELLULAR RECOGNITION CONJUGATES AND METHODS OF USE FOR THE HISTOLOGICAL ANALYSIS OF CANCER TISSUE USING MALDI-MS IMAGING | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2014-10-23 | — | — | US | disclosed |
| US-20070140973-A1 | CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2007-06-21 | — | — | US | disclosed |
| WO-2007070827-A2 | CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2007-06-21 | — | — | WO | disclosed |
| US-6916660-B2 | Fluorescent sensor compounds for detecting saccharides | NORTH CAROLINA STATE UNIVERSITY (US) | 2005-07-12 | — | — | US | disclosed |
| US-20040048390-A1 | Fluorescent sensor compounds for detecting saccharides | NORTH CAROLINA STATE UNIVERSITY | 2004-03-11 | — | — | US | disclosed |
| WO-2003094926-A1 | FLUORESCENT SENSOR COMPOUNDS FOR DETECTING SACCHARIDES | NORTH CAROLINA STATE UNIVERSITY (US) | 2003-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070140973-A1 | CONTRAST AGENTS FOR MYOCARDIUM PERFUSION IMAGING | TNNI3, TNNT2, TNNC1 | HTR2C 3849/4885SLC6A4 98/4885CTSL 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.